Pulse Stim-Free Fruit Punch

Pulse Stim-Free Fruit Punch

Legion4.6 (54 ratings)
Format:Powder Quantity: 435 Gram(s) · 21 servings
Goals
$44.99 $2.14 per serving

Product analysis

49 out of 100

Pulse Stim-Free Fruit Punch offers a stimulant-free formula with potassium that contributes to electrolyte balance. Its high cost for Alpha-GPC and calcium weakens value.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality47

Potassium is supplied in a suitable citrate form, but the quality of most other preparations remains uncertain. Unspecified forms limit comparison with alternatives.

Ingredient Transparency60

All listed amounts are stated, but most forms are unspecified. Missing mixture proportions also prevent a complete comparison.

Value For Money28

The calcium and Alpha-GPC contributions are costly, while value for sodium and potassium is middling. Value for the other assessed ingredients remains uncertain.

Customer Satisfaction68

Customer ratings are positive, but the review count is small. That leaves a limited picture of customer satisfaction.

Product Focus45

Potassium contributes to normal electrolyte balance, while Alpha-GPC has limited preparation-specific attention evidence. Neither establishes a predictable blood-pressure reduction or lasting memory improvement.

Format
Powder
Container
435 Gram(s)
Per serving
$2.14
Customer rating
4.6 · 54 ratings
Report analysis

Goals

Impact
Moderate effect
C Ingredient FitF PathwaysC- EvidenceA+ Formulation Logic

Potassium at 270 mg contributes to electrolyte balance and blood-vessel tone. That provides limited nutritional support; it should not be read as a predictable blood-pressure reduction from one serving.

How this product is rated for Heart Health

Ingredient fit62

Relevant ingredients are part of a formula serving several other purposes, giving limited heart-specific focus. The assessed amounts receive full dose support in the saved findings.
Goal fit
Relevant ingredients are part of a formula serving several other purposes, giving limited heart-specific focus.
Dose adequacy
The assessed amounts receive full dose support in the saved findings.

Pathways19

The strongest saved contribution relates to electrolyte and vascular-tone balance, with limited coverage. No reviewed pathway reaches the saved coverage threshold, so support remains narrow.
Depth
The strongest saved contribution relates to electrolyte and vascular-tone balance, with limited coverage.
Breadth
No reviewed pathway reaches the saved coverage threshold, so support remains narrow.

Evidence60

Potassium provides the strongest effective ingredient evidence in the saved assessment; its support remains bounded to the reviewed nutritional or surrogate outcomes.
Evidence strength
Potassium provides the strongest effective ingredient evidence in the saved assessment; its support remains bounded to the reviewed nutritional or surrogate outcomes.
Studied preparation
The effective ingredients match preparations accepted in the saved review.

Formulation logic100

The reviewed contributors work independently or have their required partners. No matched ingredient conflict was recorded in the saved assessment.
Partner coverage
The reviewed contributors work independently or have their required partners.
Conflicts
No matched ingredient conflict was recorded in the saved assessment.
Effective doses
All assessed contributors meet the saved minimum dose threshold.
Study evidence
Potassium Supportive 182 studies
Brain Health
Impact
Lower effect
D- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 300 mg
Study evidence
Alpha-GPC Supportive 12 studies
Longevity
Impact
Lower effect
D- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 300 mg
Study evidence
Alpha-GPC Not classified

No linked studies yet.

Cognitive Support
Impact
Moderate effect
C Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 300 mg

Alpha-GPC supplies a choline-related ingredient involved in acetylcholine signalling. The 300 mg declaration is close to the lower active amount in a small acute exercise-related attention trial, but unidentified material cannot be assumed to contain the same active exposure or to improve long-term memory.

How this product is rated for Cognitive Support

Ingredient fit60

Alpha-GPC is relevant, but the wider composition mainly serves exercise-related purposes.
Goal fit
Alpha-GPC is relevant, but the wider composition mainly serves exercise-related purposes..
Dose adequacy
The 300 mg Alpha-GPC closely approaches the saved exposure reference.

Pathways17

Acetylcholine signalling is the main area represented in the saved findings. No core area reaches the saved meaningful-coverage threshold.
Depth
Acetylcholine signalling is the main area represented in the saved findings.
Breadth
No core area reaches the saved meaningful-coverage threshold.

Evidence28

Alpha-GPC supplies preliminary acute-task evidence from a small exercise-related trial. The relevant material is not identified as a studied cognitive preparation.
Evidence strength
Alpha-GPC supplies preliminary acute-task evidence from a small exercise-related trial.
Studied preparation
The relevant material is not identified as a studied cognitive preparation.

Formulation logic100

The relevant ingredients can contribute without an additional required partner. All ingredients counted in the saved effective-exposure finding reach its minimum level.
Partner coverage
The saved assessment finds no missing required partner for the relevant ingredients.
Conflicts
No listed cognitive-performance conflict was found in the supplied assessment.
Effective doses
All ingredients counted in the saved effective-exposure finding reach its minimum level.
Study evidence
Alpha-GPC Supportive 15 studies
Productivity Boost
Impact
Lower effect
C Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Alpha-GPC · 300 mg
Study evidence
Alpha-GPC Supportive 2 studies

Ingredients

IngredientAmount per servingScore
Calories
5 Calorie(s)
Total Carbohydrates
4 Gram(s)
Calcium
236 mg 52
Sodium (Sodium Chloride, Sodium Citrate)
110 mg 66
Potassium (Tripotassium Citrate Monohydrate)
270 mg 75
L-Citrulline DL-Malate
8 Gram(s)
CarnoSyn (Beta-Alanine)
3.6 Gram(s)
Betaine Anhydrous
2.5 Gram(s)
Alphasize Alpha-Glyceryl Phosphoryl Choline
300 mg 74
Adults 18–50 Women
Report overview
A+ Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD+ Value
Each serving lists 270 mg of potassium from tripotassium citrate monohydrate, a moderate amount in this comparison. A whole-product serving costs about $2.14.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

The listed potassium form is tripotassium citrate monohydrate.
Potassium Form Quality
The listed potassium form is tripotassium citrate monohydrate.

Dose, Safety & Label Transparency64

Potassium is listed at 270 mg per serving, a moderate amount in this comparison; explicit elemental-potassium wording is not recorded in the saved facts.
Potassium Dosage Potency
The listed 270 mg of potassium per serving is a moderate amount in this comparison.
Elemental Yield Transparency
The label lists 270 mg of potassium per serving; the saved facts do not include explicit elemental-potassium wording.

Value50

A whole-product serving costs about $2.14 and provides 270 mg of potassium.
Potassium Value Efficiency
A whole-product serving costs about $2.14 and provides 270 mg of potassium.
B Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyD+ Value
A serving provides 110 mg of sodium, a modest amount for heavy sweat replacement. The recorded sources are sodium chloride and sodium citrate, with unknown proportions.
How this ingredient is rated

Active Ingredient Quality & Bioavailability75

The recorded sources are sodium chloride and sodium citrate; their shares are unknown. An accompanying electrolyte form has favorable absorption potential in the evaluation; its specific identity is not provided in the saved facts.
Sodium Source Purity & Quality
The recorded sources are sodium chloride and sodium citrate; their shares are unknown.
Bioavailability of Supporting Electrolytes
An accompanying electrolyte form has favorable absorption potential in the evaluation; its specific identity is not provided in the saved facts.
Trace Mineral Complex & Buffering Forms
The available facts do not identify added trace mineral or buffering support.

Dose, Safety & Label Transparency65

A serving provides 110 mg sodium, a modest amount for heavy sweat replacement. The available ingredient evidence does not indicate artificial colors or sweeteners.
Sodium Dosage for Athletic Replenishment
A serving provides 110 mg sodium, a modest amount for heavy sweat replacement.
Ingredient Label Transparency
Sodium is recorded at 110 mg per serving, potassium at 270 mg.
Artificial Color and Sweetener Disclosure
The available ingredient evidence does not indicate artificial colors or sweeteners.

Value50

A whole-product serving costs about $2.14; the price is for the entire product, not sodium alone.
Price Per Serving vs. Collection Median
A whole-product serving costs about $2.14; the price is for the entire product, not sodium alone.
Alpha-GPC · 300 mg OverallScore74
A+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyF Value
Each serving provides 300 mg of Alpha-GPC as AlphaSize, a branded form. Based on the whole-product price, 300 mg of Alpha-GPC works out to about $2.14, a high price in this comparison.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

The Alpha-GPC is identified as the branded AlphaSize form.
Patented/Branded Form and Source
The saved facts identify AlphaSize, a branded form of Alpha-GPC.

Dose, Safety & Label Transparency80

A serving provides 300 mg of active Alpha-GPC.
Active Alpha-GPC Dosage
A serving provides 300 mg of active Alpha-GPC.
Label Transparency & Yield Disclosure
The active Alpha-GPC amount is given as 300 mg per serving; no separate active-yield statement appears in the saved facts.

Value10

Based on the whole-product price, 300 mg of Alpha-GPC works out to about $2.14, a high price in this comparison.
Price per 300mg Active Alpha-GPC
Based on the whole-product price, 300 mg of Alpha-GPC works out to about $2.14, a high price in this comparison.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    Sagaro GG; Traini E; Amenta F · Journal of Alzheimer's disease : JAD · 2023
    Meta-analysis8 studies pooledBrain Health Cognitive Support forAlpha-GPC
  2. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M · Medicine · 2024
    Randomized trial119 participantsBrain Health Cognitive Support forAlpha-GPC
  3. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsBrain Health Cognitive Support forAlpha-GPC
  4. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
    Kerksick CM · Nutrients · 2024
    Randomized trial20 participantsBrain Health Productivity Boost forAlpha-GPC
  5. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsBrain Health forAlpha-GPC
  6. [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
    Voznyuk IA; Nepomnyashchiy IS; Kutkova AK; Tokareva DV; Prokhorova MV; Ovdiienko OA; Shusharina NN · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2025
    Meta-analysis10 studies pooledCognitive Support forAlpha-GPC
  7. Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
    Guan F; Jia X; Huang F; Zhang J; Wei Y; Li L; Bai J; Wang H · Nutrients · 2024
    Cohort study7,659 participantsCognitive Support forAlpha-GPC
  8. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  9. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  10. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study.
    O'Donnell M; Mente A; Rangarajan S; McQueen MJ; O'Leary N; Yin L; Liu X; Swaminathan S; Khatib R; Rosengren A; Ferguson J; Smyth A; Lopez-Jaramillo P; Diaz R; Avezum A; Lanas F; Ismail N; Yusoff K; Dans A; Iqbal R; Szuba A; Mohammadifard N; Oguz A; Yusufali AH; Alhabib KF; Kruger IM; Yusuf R; Chifamba J; Yeates K; Dagenais G; Wielgosz A; Lear SA; Teo K; Yusuf S; PURE Investigators · BMJ (Clinical research ed.) · 2019
    Cohort study103,570 participantsHeart Health forPotassium
  11. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  12. Effects of potassium supplementation on office, home, and 24-h blood pressure in patients with essential hypertension.
    Kawano Y; Minami J; Takishita S; Omae T · American journal of hypertension · 1999
    Randomized trial55 participantsHeart Health forPotassium
  13. Treatment of dementia with neurotransmission modulation.
    Doggrell SA; Evans S · Expert opinion on investigational drugs · 2004
    Narrative reviewProductivity Boost forAlpha-GPC